- Home
- SEGG vs OSRH Comparison
SEGG vs OSRH Comparison
Compare SEGG & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SEGG | OSRH |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | 12 | 22 |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 17.9M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | SEGG | OSRH |
|---|---|---|
| Price | $1.22 | $0.39 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 957.7K |
| Earning Date | 05-20-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $0.38 |
| 52 Week High | $7.61 | $1.79 |
Technical Indicators
Market Signals| Indicator | SEGG | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 41.02 | 36.46 |
| Support Level | $0.97 | N/A |
| Resistance Level | $1.66 | $0.47 |
| Average True Range (ATR) | 0.31 | 0.04 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 11.98 | 8.49 |
Price Performance
Historical ComparisonAbout SEGG Lottery.com Inc.
Sports Entertainment Gaming Global Corp is a sports, entertainment and gaming group operating digital assets such as Sports.com and Lottery.com. It is focused on immersive fan engagement, ethical gaming and AI-driven live experiences.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.